Showing results (1-10 of 51) with videos related to
Sort By:
Pageof 6
Autoimmunity Reviews|November 26, 2009
The geoepidemiology of the antiphospholipid antibody syndromeMartina Biggioggero, Pier Luigi MeroniDrug Development Research|November 11, 2014
Ten-year drug survival of anti-TNF agents in the treatment of inflammatory arthritidesMartina Biggioggero, Ennio Giulio FavalliRMD Open|November 12, 2015
Structural integrity versus radiographic progression in rheumatoid arthritisEnnio Giulio Favalli, Andrea Becciolini, Martina BiggioggeroThe Journal of International Medical Research|September 30, 2016
The role of methotrexate as combination therapy with etanercept in rheumatoid arthritis: Retrospective analysis of a local registryAndrea Becciolini, Martina Biggioggero, Ennio Giulio FavalliClinical Reviews in Allergy & Immunology|March 16, 2011
Cutting-edge issues in coronary disease and the primary antiphospholipid syndromeRoberta Gualtierotti, Martina Biggioggero, Pier Luigi MeroniBiomed Research International|February 9, 2019
The Use of Rheumatic Disease Comorbidity Index for Predicting Clinical Response and Retention Rate in a Cohort of Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Alpha InhibitorsMartina Biggioggero, Federica Mesina, Ennio Giulio FavalliAutoimmunity|March 20, 2010
Type I interferon therapy and its role in autoimmunityMartina Biggioggero, Lisa Gabbriellini, Pier Luigi MeroniAutoimmunity Reviews|August 31, 2014
Methotrexate for the treatment of rheumatoid arthritis in the biologic era: still an "anchor" drug?Ennio Giulio Favalli, Martina Biggioggero, Pier Luigi MeroniPatient Related Outcome Measures|August 30, 2018
Sarilumab: patient-reported outcomes in rheumatoid arthritisChiara Crotti, Martina Biggioggero, Andrea Becciolini, et al.Drug Design, Development and Therapy|December 28, 2018
Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selectionMartina Biggioggero, Chiara Crotti, Andrea Becciolini, et al.Pageof 6